• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Study finds nearly half of people with diabetes skip care due to costs

June 18, 2018 By Sarah Faulkner

diabetesA newly-published report from UpWell Health found that nearly half of Americans with diabetes have skipped medical care at times because they couldn’t afford it.

The 5,000-person survey showed that diabetes doesn’t just take a financial toll on people’s lives – it can impact their relationships, too; 37% of respondents reported that diabetes has harmed relationships with loved ones and co-workers.

The American Diabetes Association reported this year that the average person with diabetes incurs $7,900 each year in diabetes-related medical expenses. While some of those costs are covered by insurance, 43% of UpWell Health’s survey respondents reported paying up to $1,000 out-of-pocket in the past year.

The company’s report also found that more than half of the respondents missed work in the past year thanks to diabetes and nearly four in 10 had to give up their hobbies or activities.

“The report shines a light on the impact diabetes can have on one’s lifestyle and amplifies the real disconnect that often exists between physicians, pharmacists, insurance providers, and patients, which can lead to patient frustration and further disease progression,” UpWell Health CEO Alison Wistner said in prepared remarks.

“There is a tremendous opportunity to simplify chronic care management by giving patients the ability and resources to obtain their medications and adhere to their prescription plan. We feel that doing so will help people live simpler, healthier, and more empowered lives,” Wistner added.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, Pharmaceuticals Tagged With: americandiabetesassociation

IN CASE YOU MISSED IT

  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
  • Medtronic to separate Diabetes business unit

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS